Trump nabs secret slice of Aussie drug prices

Pfizer and Eli Lilly will give the US government a share of the increased revenue they generate from raising prices in other countries, contracts related to their Most Favoured Nation (MFN) drug pricing deals suggest.

To see the whole article please log in.

Simon Webster

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here